18.43  -0.01 (-0.05%)		10-30 16:00
Open: 18.44 High: 18.46 Volume: 460,697		Pre. Close: 18.44 Low: 18.42 Market Cap: 783(M)

Short term
Mid term
Targets	6-month :	21.6	1-year :	25.23
Resists	First :	18.5	Second :	21.6
Pivot price	18.43
Supports	First :	18.4	Second :	18.35
MAs	MA(5) :	18.43	MA(20) :	18.43
	MA(100) :	15.35	MA(250) :	13.26
MACD	MACD :	0	Signal :	0.1
%K %D	K(14,3) :	60	D(3) :	62.2
RSI	RSI(14): 59.7
52-week	High :	18.62	Low :	9.09

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ VREX ] has closed above bottom band by 49.4%. Bollinger Bands are 94.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 44 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	18.48 - 18.63	18.63 - 18.73
Low:	18.1 - 18.27	18.27 - 18.38
Close:	18.21 - 18.47	18.47 - 18.65

Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.

Sat, 31 Oct 2026
What Varex Imaging Holders Got Right - Simply Wall St

Thu, 29 Oct 2026
Varex Imaging Corporation (VREX) Seasonal returns chart - Yahoo Finance UK

Thu, 29 Oct 2026
About 77% of shares were represented as Varex Imaging (VREX) stockholders voted on the Teledyne merger. - Stock Titan

Wed, 28 Oct 2026
Varex Imaging Shareholders Approve Teledyne Merger Agreement - TradingView

Wed, 28 Oct 2026
VREX: Stockholders approved the Teledyne merger and related executive compensation - TradingView

Thu, 22 Oct 2026
Varex Imaging Updates Merger Proxy Amid Lawsuits; Regulatory Reviews Remain Pending - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	42 (M)
Shares Float	41 (M)
Held by Insiders	1.7 (%)
Held by Institutions	92.5 (%)
Shares Short	1,650 (K)
Shares Short P.Month	1,250 (K)

EPS	0.52
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	11.77
Profit Margin	2.5 %
Operating Margin	10.8 %
Return on Assets (ttm)	4.1 %
Return on Equity (ttm)	4.5 %
Qtrly Rev. Growth	3.7 %
Gross Profit (p.s.)	6.99
Sales Per Share	20.37
EBITDA (p.s.)	2.34
Qtrly Earnings Growth	0 %
Operating Cash Flow	11 (M)
Levered Free Cash Flow	-40 (M)

PE Ratio	34.77
PEG Ratio	4.9
Price to Book value	1.56
Price to Sales	0.9
Price to Cash Flow	69.25

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.